Public consultation on assessment results for Type 1 use of a recombinant live vaccine for dogs
犬用遺伝子組換え生ワクチンの第一種使用等に関する審査結果についての意見・情報の募集（パブリックコメント）について
Published: 2026-10-27 · Source: Ministry of Agriculture, Forestry and Fisheries (MAFF) · Stage: Public Comment Results Published · Area: Food / Agriculture · Impact (preliminary): Low · First detected by this dashboard: 2026-10-28
View the original Japanese source More Food / Agriculture updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The Ministry of Agriculture, Forestry and Fisheries announced a public consultation on 2026-10-27 concerning assessment results for Type 1 use and related activities involving a genetically modified live vaccine for dogs. The supplied title does not specify a comment deadline or establish that the vaccine has been approved.
Business Impact
Developers and suppliers of the genetically modified live vaccine for dogs may be affected by the assessment of its Type 1 use and related activities, although the title does not identify specific conditions or restrictions.
Recommended Action
Reviewing the official announcement and accompanying assessment materials may clarify the vaccine covered, the scope of Type 1 use and related activities, and the consultation deadline.